
Ovarian Cancer Drugs News Monitoring
-
Published on 15:02 GMTSource: Endpoints News - Neutral
-
Published on Jul 30, 2025
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
For their analysis, researchers focused on CSC-associated biomarkers in ovarian cancer, targeting them via radiolabeled immunoconjugates with either 177Lu or 161Tb. The team then assessed radioimmunoconjugate quality by determining radiochemical purity and …
Source: Health Imaging - Neutral -
Published on Jul 30, 2025
CLD-201 Receives FDA Fast Track Designation Targeting Sarcoma
The investigational allogeneic adipose stem cell-loaded oncolytic virus, CLD-201 (SuperNova), has been granted fast track designation by the US FDA for the treatment of soft tissue sarcoma. This designation aims to expedite the development and review …
Source: Targeted Oncology - Pending -
Published on 13:18 GMT
LiFT Biosciences bags €12m grant to advance novel cell therapy to clinical trials
Early-stage biotech LiFT Biosciences has secured €12m ($13.74m) in funding from Ireland’s Disruptive Technologies Innovation Fund (DTIF) to advance its novel IMAN cell therapy platform to clinical trials. Composed of immunomodulatory anti-tumour …
Source: Clinical Trials Arena - Pending -
Published on Jul 30, 2025
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued
IMUNON, Inc. (IMNN) said on Wednesday its first patient has been dosed with the firm’s lead candidate, IMNN-001, as part of a late-stage trial evaluating the drug in the treatment of women with newly diagnosed advanced ovarian cancer. Shares of the company …
Source: Asianet Newsable - Center-right -
Published on Jul 30, 2025
Frost & Sullivan Released Report: 'Nuoyuan Medical: Class I New Drug Pemefolacianine Completes Phase I ...
Breadcrumb Trail Links Newsfile Article content Shanghai, China–(Newsfile Corp. – July 30, 2025) – Frost & Sullivan released a report titled, “Nuoyuan Medical: Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative …
Source: The Kingston Whig-Standard - Neutral -
Published on Jul 28, 2025
MHRA grants marketing authorisation for AbbVie’s ovarian cancer treatment
AbbVie has announced that it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE®▼ (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult patients with folate …
Source: Pf Media - Neutral -
Published on Jul 30, 2025
Frost & Sullivan Released Report:“Nuoyuan Medical: Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, ...
(MENAFN- GetNews) Frost & Sullivan released a report titled "Nuoyuan Medical: Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis." The report highlights how Nanjing Nuoyuan Medical …
Source: MENAFN - Indeterminate -
Published on Jul 28, 2025
AbbVie’s Elahere granted MHRA approval to treat platinum-resistant ovarian cancer
AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with ovarian, fallopian tube and primary peritoneal cancer. The antibody drug conjugate (ADC) has been …
Source: PMLiVE - Neutral -
Published on 13:37 GMT
USC researchers pioneer lifesaving cancer breakthroughs
Several years ago, Heinz-Josef Lenz, a professor of medicine and cancer biology at the Keck School of Medicine of USC and the J. Terrence Lanni Chair in Gastrointestinal Cancer Research, made a surprising discovery about colon cancer. He and his research …
Source: University of Southern California - Pending -
Published on 16:59 GMT
Ovarian tumor immune landscapes offer clues to better therapy
July 31, 2025, NEW YORK – The immune system is a major determinant of how patients respond to standard treatments for ovarian cancer, the leading cause of death from gynecological malignancies. But little was known about how the immune landscape of tumors …
Source: The National Tribune - Center-left -
Published on 11:33 GMT
BriaCell's subsidiary, BriaPro seeks patent for immuno─oncology platform with novel multitargeting agents
BriaCell Therapeutics Corp. (BriaCell), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority owned subsidiary, BriaPro Therapeutics Corp. (BriaPro), announced that BriaPro is developing novel …
Source: Pharmabiz.com - Neutral -
Published on 18:58 GMT
What Is Hysterectomy? Untold Side Effects Of Uterus Removal On Women’s Health
According to NIH, only 5 out of 100 women experience health complication, regardless, it is always a good idea to guard yourself and your loved once from risks by learning and sharing awareness about side effects of hysterectomy. Hysterectomy is a uterus …
Source: The Health Site - Pending -
Published on 10:30 GMT
How even stage 4 cancer won't alter TN woman's Senior…
81-year-old Carol Stricklin has competed in the Senior Olympics for more than 25 years, winning over 500 medals. Stricklin, a former IBM employee, aims to compete in the Senior Olympics until she's 100. She finds joy in encouraging others to …
Source: Memphis Commercial Appeal - Tennessee - Neutral -
Published on 08:19 GMT
Breast Milk For Sale: Mothers Making Millions Online. But Is It Safe For Other Babies?
Last Updated:July 31, 2025, 11:28 IST Women in the US are earning millions by selling breast milk, but is it safe for babies? Discover 5 essential facts about the benefits and risks of buying breast milk Despite its growing popularity, the US Food and Drug …
Source: News18 - Center-right -
Published on 12:56 GMT
Metabolism-Mediated FGF5 Association with Stroke: Based on Mendelian Randomization and Bioinformatics Analysis
Introduction Stroke is the second most common cause of death globally among non-communicable diseases (NCDs) and ranks third as a combined cause of mortality and disability, as reflected by the loss of disability-adjusted life years (DALY).1 With the …
Source: Dove Medical Press - Neutral -
Published on Jul 28, 2025
Drug Trials Snapshot: AVMAPKI FAKZYNJA CO-PACK
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, and whether there were differences among sex, race, age, and ethnic groups. The “ …
Distribution channels: Healthcare & Pharmaceuticals Industry -
Published on Jul 29, 2025
US FDA grants priority review and breakthrough therapy designation to AstraZeneca's sBLA for Imfinzi to treat patients ...
AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric …
Source: Pharmabiz.com - Neutral -
Published on Jul 28, 2025
'I’m just scared!': Insurance denials halt chemo treatment for Fla. woman with 'aggressive' breast cancer
“I’m just scared!” Mary Barnes and her husband, Tom, love putting puzzles together. “We enjoy it,” she said while working on her latest puzzle. “They’re tough too, she said. But recently, Mary has had to face a puzzle of a lifetime, she just can’t piece …
Source: WFTS Tampa Bay - Florida - Neutral
Featured Releases
-
Published on July 31, 2025 - 19:09 GMT
Rosemont Pharmaceuticals announces FDA Approval of VOSTALLY®(ramipril) Oral Solution for treatment of adult hypertension
Rosemont Pharmaceuticals announces FDA Approval of VOSTALLY® (ramipril) Oral Solution for the treatment of hypertension in adults to lower blood pressure. GREENVILLE, MS, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Rosemont Pharmaceuticals, Inc. …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 16:20 GMT
Press release: Online availability of Sanofi’s half-year financial report for 2025
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorite …
Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
-
Published on July 31, 2025 - 16:20 GMT
Communiqué de presse : Mise en ligne du rapport financier semestriel 2025 de Sanofi
Mise en ligne du rapport financier semestriel 2025 de Sanofi Paris, le 31 juillet 2025. Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son rapport financier semestriel au 30 juin …
Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ... -
Published on July 31, 2025 - 14:51 GMT
Innovative Science and Technology Approaches for New Drugs (ISTAND) Program
Spotlight Events & Announcements Get Started with Your Submission The Innovative Science and Technology Approaches for New Drugs (ISTAND) Program accepts submissions for qualification of types of drug development tools (DDTs) that are out of scope for …
Distribution channels: Healthcare & Pharmaceuticals Industry
-
Published on July 31, 2025 - 14:51 GMT
Innovative Science and Technology Approaches for New Drugs (ISTAND) Program Submission Process
Submission Process The 21st Century Cures Act formally established a multi-step process for Drug Development Tools (DDT) qualification. Qualification of a DDT is for a specific context of use (COU), and the qualified DDT may be used for the COU by any …
Distribution channels: Healthcare & Pharmaceuticals Industry -
Published on July 31, 2025 - 12:44 GMT
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage …
Distribution channels: Banking, Finance & Investment Industry, Companies ... -
Published on July 31, 2025 - 12:30 GMT
Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it …
Distribution channels: -
Published on July 31, 2025 - 12:00 GMT
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7
DUBLIN, Ireland, July 31, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m …
Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Online News Monitoring Made Simple
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
News by Country & by Industry
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News Alerts & News Feeds
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Submit News
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
World Media Directory
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 07/17/2025

Healthcare & Pharmaceuticals Industry Press Releases
-
Published on July 31, 2025 - 19:41 GMT
The Future of Veneers Is Here: Dr. Joyce Kahng Partners with Neer for No-Prep Innovation
Dr. Joyce Kahng joins Neer as Founding Clinical Advisor to lead innovation in no prep veneers and minimally invasive cosmetic dentistry. COSTA MESA, ORANGE COUNTY, CA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Leading cosmetic dentist …
Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ... -
Published on July 31, 2025 - 19:32 GMT
Investment Group acquires Wanderly LLC, a Leading Healthcare Staffing Marketplace Platform
Wanderly LLC, a leading digital marketplace transforming how healthcare professionals connect with employers. MIAMI, FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Wanderly LLC, a leading digital marketplace transforming how healthcare …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 19:22 GMT
Fibr Surpasses 500 Health Clubs & Fitness Studios Nationwide in Comprehensive Recruiting
The fitness industry’s premier recruitment/networking platform Fibr supports over 500 health clubs and studios, representing more than 40 elite fitness brands. WESTLAKE VILLAGE, CA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Fibr, …
Distribution channels: Business & Economy, Companies ... -
Published on July 31, 2025 - 19:09 GMT
Rosemont Pharmaceuticals announces FDA Approval of VOSTALLY®(ramipril) Oral Solution for treatment of adult hypertension
Rosemont Pharmaceuticals announces FDA Approval of VOSTALLY® (ramipril) Oral Solution for the treatment of hypertension in adults to lower blood pressure. GREENVILLE, MS, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Rosemont Pharmaceuticals, Inc. …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 19:03 GMT
Ambrosia Launches RIZZ: The World’s First Non-Invasive Smart Ring for Glucose Trends and Whole-Body Wellness
Now available for pre-order, RIZZ brings real-time glucose, sleep, and stress tracking to your finger without sensors, pricks, or prescriptions. SAN FRANCISCO, CA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Ambrosia Systems, a pioneer in non- …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 18:56 GMT
VI Marketing and Branding Wins Five Heartland Emmy Awards for Tourism and Public Health Campaigns
OKLAHOMA CITY, OK, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- VI Marketing and Branding (VI) has earned five Heartland Emmy® Awards from the National Academy of Television Arts and Sciences (NATAS), recognizing the agency’s exceptional …
Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 18:26 GMT
Dr. Barbara Knox Leads Effort to Stop Child Abuse Nationwide
Dr. Barbara Knox is leading a powerful nationwide effort to stop child abuse. She is protecting children & guiding families toward safety. JACKSONVILLE, FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Dr. Barbara Knox, MD, a well- …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 18:03 GMT
Richmond Plastic Surgeon Highlights Non-Surgical Ways to Reduce Stubborn Fat
Dr. Neil Zemmel of Dermlounge highlights non-surgical ways to reduce stubborn fat and improve body contours without the need for surgery. RICHMOND, VA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Non-surgical body contouring continues to grow in …
Distribution channels: Beauty & Hair Care, Companies ... -
Published on July 31, 2025 - 17:30 GMT
Voyages Counseling's Neurofeedback Therapy Helps CO Residents to Rewire Their Brains for Mental Wellness and Performance
Voyages Counseling in Centennial, CO, offers Neuro Integrated Therapy (NIT), a research-backed, non-invasive neurofeedback treatment for mental wellness. CENTENNIAL, CO, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- At the intersection of …
Distribution channels: Culture, Society & Lifestyle, Education ... -
Published on July 31, 2025 - 17:03 GMT
Veteran Health Equity Leader Brian Toomey to join Mission Mobile Medical as Executive in Residence
Former CEO of Piedmont Health Services joins EIR cohort to strengthen community health partnerships. GREENSBORO, NC, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Brian Toomey, MSW, is joining Mission Mobile Medical Group as the newest …
Distribution channels: Business & Economy, Emergency Services ... -
Published on July 31, 2025 - 17:00 GMT
Neva Analytics Delivers for Biotech Innovators
Neva combines its extensive large molecule product development expertise with its ability to align with the best interests of its R&D clients. LONGMONT, CO, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Neva’s extensive large molecule …
Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ... -
Published on July 31, 2025 - 16:19 GMT
A Beautiful Smile Dentistry Launches 'SnoreNoMoreDr.com' Program to Help NJ PBA, FMBA members and First Responders
FORT LEE, NJ, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- A Beautiful Smile Dentistry is proud to introduce Snore No More Doctors (SNM), a new, non-invasive sleep apnea treatment program specifically designed to help New Jersey’s first …
Distribution channels: Consumer Goods, Culture, Society & Lifestyle ... -
Published on July 31, 2025 - 16:04 GMT
Stand Up For Science launches '31 Days of Action' campaign to defend science.
Activism campaign will rally the public around the vital role of science for communities across America. WASHINGTON, DC, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Tomorrow, Stand Up For Science launches "31 Days of Action," a …
Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ... -
Published on July 31, 2025 - 16:00 GMT
Naples Laser & Skin Aesthetics Helps Upgrade Your Look With Professional Lip Fillers
Naples Laser & Skin Aesthetics Enhances Your Look with Expert Lip Filler Treatments NAPLES, FL, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Naples Laser & Skin Aesthetics Helps Upgrade Your Look With Professional Lip Fillers Naples …
Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ... -
Published on July 31, 2025 - 16:00 GMT
National Infusion Collaborative Launches Listserv to Strengthen Communication Among Infusion Leaders Nationwide
PHILADELPHIA, PA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- The National Infusion Collaborative (NIC) is proud to announce the launch of its official Listserv, a new digital forum designed to support open dialogue, resource sharing, and peer …
Distribution channels: Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 15:55 GMT
Techcyte and Hamamatsu Corporation (U.S.) Announce Distribution Agreement to Facilitate Scanner Access for Labs
OREM, UT, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Techcyte, a leader in AI-powered digital pathology, has signed a distribution agreement with Hamamatsu Corporation (U.S.). This agreement enables Techcyte to streamline access to …
Distribution channels: Business & Economy, Companies ... -
Published on July 31, 2025 - 15:55 GMT
Statewise Welcomes Kelly Burgess as Senior Account Representative, Expanding Commitment to the IDD Provider Community
Statewise, a leading provider of purpose-built software for Medicaid agencies and providers, announces the addition of Kelly Burgess to their growing team. FORT WORTH, TX, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Statewise, a leading …
Distribution channels: Business & Economy, Companies ... -
Published on July 31, 2025 - 15:51 GMT
Thomas & Wan, LLP Marks 19 Years of Pursuing Justice for Medical Malpractice Clients
HOUSTON, TX, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Thomas & Wan, LLP, a boutique law firm dedicated exclusively to medical malpractice and birth injury representation, is proud to announce the celebration of its 19th year of …
Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ... -
Published on July 31, 2025 - 15:51 GMT
Stanton Optical Opens New Store in Indianapolis, IN
Full-Service Eye Care, Offering Hi-tech Eye Exams, Eye Health Solutions and Affordable Eyewear INDIANAPOLIS, IN, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Stanton Optical, a pioneer in affordable and accessible eye care, announces the …
Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ... -
Published on July 31, 2025 - 15:50 GMT
Incredable’s DEA Lookup Integration Enables Real-Time DEA Verification to Accelerate Credential Approvals
Incredable integrates DEA Lookup.com to automate controlled substance verification and accelerate provider approvals. AUSTIN, TX, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Incredable, the AI-powered credentialing platform developed by parent …
Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Healthcare & Pharmaceuticals Events
No event was found.

- Track news from thousands of sources
- Submit news sources for inclusion in our news tracking algorithm
- Build your own customized email newsletters
- Use of our RSS Feeds
- Includes a complimentary EIN Presswire account plus 1-free release
- Uncluttered & advertising free news pages